METHODS AND DEVICES FOR FOLLOW-UP CARE AND TREATMENT OF A PNEUMOSTOMA

• US 20090205665A1
• Filed: 02/18/2009
• Published: 08/20/2009
• Est. Priority Date: 02/19/2008
• Status: Abandoned Application

• Current Assignee: Portaero, Inc
• Original Assignee: Portaero, Inc
• Inventors: Plough, David C., Tanaka, Don, Wiesman, Joshua P.
• Application Number:
  US12/388,459
• Publication Number:
  US 20090205665A1
• Time in Patent Office: Days
• US Class Current: 128/205.270
• CPC Class Codes: A61B 2017/00809 Lung operations
• CPC Class Codes: A61K 9/007 Pulmonary tract; Aromatherapy
• CPC Class Codes: A61M 1/04 Artificial pneumothorax apparatus
• CPC Class Codes: A61M 11/00 Sprayers or atomisers specially adapted for therapeutic purposes in general B05B; aerosol containers B65D83/14
• CPC Class Codes: A61M 11/005 using ultrasonics spraying or atomising liquids using ultrasonic vibrations in general B05B17/06
• CPC Class Codes: A61M 11/042 electrical
• CPC Class Codes: A61M 13/00 Insufflators for therapeutic or disinfectant purposes , i.e. devices for blowing a gas, powder or vapour into the body hand-held units in which gas flow is produced by muscular energy at the moment of use B05B11/062
• CPC Class Codes: A61M 15/0085 using ultrasonics spraying or atomising liquids using ultrasonic vibrations in general B05B17/06
• CPC Class Codes: A61M 15/009 using medicine packages with incorporated spraying means, e.g. aerosol cans pocket atomiser of the injector type A61M11/08
• CPC Class Codes: A61M 15/02 with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
• CPC Class Codes: A61M 16/0816 Joints or connectors
• CPC Class Codes: A61M 16/0833 T- or Y-type connectors, e.g. Y-piece
• CPC Class Codes: A61M 16/202 electrically actuated
• CPC Class Codes: A61M 2039/0252 for access to the lungs
• CPC Class Codes: A61M 2039/0276 for introducing or removing fluids into or out of the body
• CPC Class Codes: A61M 2202/0208 Oxygen
• CPC Class Codes: A61M 2202/025 Helium
• CPC Class Codes: A61M 2202/064 Powder
• CPC Class Codes: A61M 2205/075 Bulb type
• CPC Class Codes: A61M 2205/7518 bacterial
• CPC Class Codes: A61M 2205/7536 : allowing gas passage, but preventing liquid passage, e.g. liquophobic, hydrophobic, water-repellent membranes
• CPC Class Codes: A61M 25/02 : Holding devices, e.g. on the body
• CPC Class Codes: A61M 25/04 : in the body, e.g. expansible A61M25/10, A61M16/0488 take precedence
• CPC Class Codes: A61M 25/10 : Balloon catheters A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02; inflatable balloons for placing stents or stent-grafts A61F2/958 ; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00
• CPC Class Codes: A61M 27/00 : Drainage appliance for wounds or the like , i.e. wound drains, implanted drains negative pressure wound therapy devices A61M1/90; implements for holding wound open A61B17/02 ; middle ear drainage A61F11/202
• CPC Class Codes: A61M 39/02 : Access sites
• CPC Class Codes: A61M 39/0247 : Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body peritoneal dialysis catheters A61M1/285; tracheostomy devices A61M16/0465; measuring pressure within the body A61B5/03; colostomy devices A61F5/445; gastrotomy feeding tubes A61J15/0015; means for fixing a feeding tube outside of the body A61J15/0053

Abstract

A pneumostoma assessment and treatment system includes methods and devices for aftercare of a pneumostoma and for additional patient care utilizing a pneumostoma. The system utilizes a number of modalities to assess the health and functionality of the pneumostoma, the lungs and/or the patient as a whole. In response to an assessment of the health and functionality of the pneumostoma, lungs and patient, the tissues of pneumostoma may be treated with a treatment device and utilizing one or more different modalities to preserve or enhance the health and function of the pneumostoma and/or treat other conditions of the patient.

Claims

1. A method for treating a pneumostoma into a lung of a patient comprising;

(a) removing a pneumostoma management device from the pneumostoma;

(b) inserting the treatment part of a pneumostoma treatment instrument into the pneumostoma;

(c) treating the pneumostoma with the treatment part so as to maintain and/or enhance escape of gases from the lung through the pneumostoma;

(d) removing the treatment part of the pneumostoma treatment instrument from the pneumostoma; and

(e) inserting a pneumostoma management device into the pneumostoma.

2. The method of claim 1, wherein the method steps are performed in the order of (a), (b), (c), (d) then (e).

3. The method of claim 1, further comprising:

(f) selecting a pneumostoma treatment instrument for treating the pneumostoma prior to step (b).

4. The method of claim 1, further comprising:

(f) determining a dimension of the pneumostoma; and

(g) configuring the pneumostoma treatment instrument based on the dimension of the pneumostoma prior to step (b).

5. The method of claim 1, further comprising:

(f) selecting a portion of a tissue of the pneumostoma being less than all of the tissue of the pneumostoma to treat with the treatment part;

wherein step (b) comprises inserting the treatment part of the pneumostoma treatment instrument into the pneumostoma so as to treat a portion of tissue of the pneumostoma selected in step (f); and

,

wherein step (c) comprises treating the portion of tissue of the pneumostoma selected in step (f) with the pneumostoma treatment part so as to maintain and/or enhance the escape of gases from the lung through the pneumostoma without treating other tissue of the pneumostoma with the treatment part.

6. The method of claim 1, further comprising the step of:

(f) applying one or more of suction and irrigation to the pneumostoma.

7. The method of claim 1, further comprising the step of

(f) applying one or more of suction and irrigation to the pneumostoma after step (c) and before step (e).

8. The method of claim 1, wherein the pneumostoma treatment device comprises an energy source and wherein the method comprises:

(c) applying energy to the pneumostoma with the treatment part so as to maintain and/or enhance the escape of gases from the lung through the pneumostoma.

9. The method of claim 1, wherein the pneumostoma treatment device comprises an electromagnetic energy source and wherein the method comprises:

(c) applying electromagnetic energy to the pneumostoma with the treatment part so as to maintain and/or enhance the escape of gases from the lung through the pneumostoma.

10. The method of claim 1, wherein the pneumostoma treatment device comprises a sound source, wherein the sound source supplies one or more of infrasound, acoustic sound and infrasound and wherein the method comprises:

(c) applying sound to the pneumostoma with the treatment part so as to maintain and/or enhance the escape of gases from the lung through the pneumostoma.

11. The method of claim 1, wherein the pneumostoma treatment part comprises a temperature-controlled surface and wherein the method comprises:

(b) inserting the treatment part of the pneumostoma treatment instrument into the pneumostoma so as to bring the temperature-controlled surface into contact with a tissue of the pneumostoma; and

(c) treating the tissue of the pneumostoma with the treatment part by changing the temperature of the tissue away from body temperature for a selected period of time so as to maintain and/or enhance the escape of gases from the lung through the pneumostoma.

12. The method of claim 1, wherein the pneumostoma treatment part comprises a temperature-controlled surface and wherein the method comprises:

(b) inserting the treatment part of the pneumostoma treatment instrument into the pneumostoma so as to bring the temperature-controlled surface into contact with a tissue of the pneumostoma; and

(c) treating the tissue of the pneumostoma with the temperature-controlled surface of the treatment part by cooling the tissue to a temperature lower than body temperature for a selected period of time so as to maintain and/or enhance the escape of gases from the lung through the pneumostoma.

13. A method for treating a tissue of a surgically-created passage which passes through a thoracic wall, parietal membrane and visceral membrane into a lung of a patient and through which gasses may escape from the lung, the parietal membrane being sealed to the visceral membrane surrounding the passage, wherein the method comprises;

(a) selecting a treatment device having a treatment probe;

(b) inserting the treatment probe of the treatment device into the passage;

(c) treating a tissue of the passage with the treatment probe;

(d) removing the treatment probe from the passage; and

(e) inserting a tube into the passage through which gases may escape the lung via the chest wall.

14. The method of claim 13, wherein step (c) comprises treating a tissue of the passage with the treatment probe to enhance escape of gases from the lung through the passage.

15. The method of claim 13, wherein the method steps are performed in the order (a) (b) (c) (d) (e).

16. The method of claim 13, further comprising:

(f) determining a dimension of the passage; and

(g) configuring the treatment device based on the dimension of the passage prior to step (b).

17. The method of claim 13, further comprising:

(f) selecting a tissue of the passage being less than all of the tissue of the passage to treat with the treatment device; and

wherein step (c) comprises selectively treating the portion of a tissue of the passage selected in step (f) with the treatment probe without treating other tissues of the passage with the treatment part.

18. The method of claim 13, further comprising the step of

(f) applying one or more of suction and irrigation to the passage after step (b) and before step (e).

19. The method of claim 13, wherein the treatment device comprises a means for transmitting energy and wherein the method comprises:

(c) applying energy to a tissue of the passage with the treatment probe.

20. The method of claim 13, wherein the treatment probe comprises a coolable surface and wherein the method comprises:

(b) inserting the treatment probe into the passage so as to bring the coolable surface into contact with a tissue of the passage; and

(c) treating the tissue of the passage with the coolable surface of the treatment part by cooling the tissue to a temperature lower than body temperature for a selected period of time.

21. A method for treating a tissue of a stoma which passes through a thoracic wall, parietal membrane and visceral membrane into a lung of a patient and through which gasses may escape from the lung, the parietal membrane being sealed to the visceral membrane surrounding a passage, wherein the method comprises;

(a) selecting a treatment device having a treatment probe;

(b) measuring a dimension of the stoma;

(c) configuring the treatment probe in response to the dimension of the stoma;

(d) inserting the treatment probe into the stoma;

(e) treating a tissue of the stoma with the treatment probe so as to promote the escape of gases from the lung through the stoma; and

(f) removing the treatment probe from the stoma.

22. The method of claim 21 further comprising:

(g) selecting some but not all of the tissue of the stoma to treat with the treatment probe so as to promote the escape of gases from the lung through the stoma; and

wherein step (c) comprises selectively treating the some but not all of the tissue of the stoma selected in step (g) with the treatment probe so as to promote the escape of gases from the lung through the stoma.

23. The method of claim 21, further comprising the step of

(g) removing a material from the stoma.

24. The method of claim 21, further comprising:

(g) inserting a tube into the stoma through which gases may escape the lung via the chest wall.

25. The method of claim 21, wherein the treatment device comprises a means for transmitting energy and wherein the method comprises:

(c) applying energy to a tissue of the stoma with the treatment probe.